The "CBD Product Safety and Standardization Act of 2023" is a federal bill aimed at regulating the safety and quality standards for CBD (cannabidiol) products in the United States. The main provisions of the bill include establishing testing requirements to ensure accurate labeling of CBD products, setting limits on THC (tetrahydrocannabinol) content, and creating a framework for product consistency and quality control. This legislation seeks to protect consumers by providing clear guidelines for manufacturers, promoting transparency in labeling, and ensuring that CBD products meet certain safety standards. If passed, this bill could have a significant impact on the CBD industry by improving consumer trust, enhancing product quality, and fostering a more regulated market for CBD products.
2023-03-17: Introduced in House
2023-03-17: Referred to the House Committee on Energy and Commerce.
2023-03-24: Referred to the Subcommittee on Health.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..